BUZZ-ChromaDex surges on surprise Q3 profit

Reuters11-01

** Biotech co ChromaDex's shares rise ~17.7% to $4.10 premarket

** CDXC, late on Thursday, reported Q3 profit of 2 cents/shr vs analysts' estimate of breakeven - LSEG data

** Co's Q3 revenue of $25.58 mln beat analysts' estimate of $23.64 mln on strong demand for its NAD (nicotinamide adenine dinucleotide) supplement

** NAD is an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body

** Up to last close, stock more than doubled YTD

(Reporting by Christy Santhosh)

((Christy.Santhosh@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2480831818?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-01 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2480831818","market":"us","top_or_hot":-1,"title":"BUZZ-ChromaDex surges on surprise Q3 profit","media":"Reuters","content":"<html><body><p>** Biotech co ChromaDex's    shares rise ~17.7% to $4.10 premarket</p><p>   ** CDXC, late on Thursday, reported Q3 profit of 2 cents/shr vs analysts' estimate of breakeven - LSEG data</p><p>   ** Co's Q3 revenue of $25.58 mln beat analysts' estimate of $23.64 mln on strong demand for its NAD (nicotinamide adenine dinucleotide) supplement</p><p>   ** NAD is an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body</p><p>   ** Up to last close, stock more than doubled YTD</p><p> (Reporting by Christy Santhosh)</p><p>((Christy.Santhosh@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-ChromaDex surges on surprise Q3 profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-ChromaDex surges on surprise Q3 profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-01 21:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Biotech co ChromaDex's    shares rise ~17.7% to $4.10 premarket   ** CDXC, late on Thursday, reported Q3 profit of 2 cents/shr vs analysts' estimate of breakeven - LSEG data   ** Co's Q3 revenue of...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2480831818","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2480831818","pubTimestamp":1730466314,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Biotech co ChromaDex's    shares rise ~17.7% to $4.10 premarket   ** CDXC, late on Thursday, reported Q3 profit of 2 cents/shr vs analysts' estimate of breakeven - LSEG data   ** Co's Q3 revenue of $25.58 mln beat analysts' estimate of $23.64 mln on strong demand for its NAD  supplement   ** NAD is an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body   ** Up to last close, stock more than doubled YTD ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","CDXC":"Chromadex Corporation"},"translate_title":"BUZZ-ChromaDex第三季度利润意外飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDXC":1},"content_text":"** Biotech co ChromaDex's    shares rise ~17.7% to $4.10 premarket   ** CDXC, late on Thursday, reported Q3 profit of 2 cents/shr vs analysts' estimate of breakeven - LSEG data   ** Co's Q3 revenue of $25.58 mln beat analysts' estimate of $23.64 mln on strong demand for its NAD (nicotinamide adenine dinucleotide) supplement   ** NAD is an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body   ** Up to last close, stock more than doubled YTD (Reporting by Christy Santhosh)((Christy.Santhosh@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2480831818"}